RxDoctor Payments Data

Sandra Felder, MD

Psychiatry · Upton, MANPI 1164583548

Payments from drug & device makers

$528in general payments, 2019–2025

Across 33 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vanda Pharmaceuticals Inc.$174
  • Sunovion Pharmaceuticals Inc.$60
  • Alkermes, Inc.$52
  • Axsome Therapeutics, Inc.$35
  • Sage Therapeutics, LLC$34
  • Teva Pharmaceuticals USA, Inc.$30
  • plus $144 from 6 others

What the payments were for

  • Food & beverage$35467%
  • Education$17433%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$528 in reported general payments places this provider in the 80th percentile of 1,431 psychiatry providers in Massachusetts.

See all psychiatry providers in Massachusetts

Medicare billing

Part B allowed, 2024
$101,360
Medicare patients
131
Services billed
836

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine32$237,931
IngrezzaValbenazine Tosylate28$220,669
RexultiBrexpiprazole48$77,749
TrintellixVortioxetine Hydrobromide103$67,361
Abilify MaintenaAripiprazole19$57,618
VraylarCariprazine Hcl23$41,253
Invega SustennaPaliperidone Palmitate14$37,067
Aripiprazole318$32,166
Aristada InitioAripiprazole Lauroxil,submicr.12$31,532
VivitrolNaltrexone Microspheres13$21,961
AuvelityDextromethorphan Hbr/Bupropion20$17,183
Lurasidone Hcl30$15,670
Clozapine181$10,934
XanaxAlprazolam12$9,536
Trazodone Hcl337$4,090

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$30$237,93132 claims
Neurocrine Biosciences, Inc.Ingrezza$17$220,66928 claims
Alkermes, Inc.Aristada Initio, Vivitrol$52$53,49225 claims
AbbVieVraylar$23$41,25323 claims
Johnson & JohnsonInvega Sustenna$27$37,06714 claims
Axsome Therapeutics, Inc.Auvelity$35$17,18320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,431 psychiatry providers in Massachusetts.

Other psychiatry in Upton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →